ATE171375T1 - Pharmazeutische zusammensetzung, die als hilfsmittelbehandlung von seborrhoid-dermatitis, auch bei hiv-patienten, verwendbar ist - Google Patents

Pharmazeutische zusammensetzung, die als hilfsmittelbehandlung von seborrhoid-dermatitis, auch bei hiv-patienten, verwendbar ist

Info

Publication number: ATE171375T1
Authority: AT; Austria
Prior art keywords: dermatitis; seborrhoid; pharmaceutical composition; additional treatment; hiv patients
Prior art date: 1991-06-18

Application number

AT92830252T

Other languages

English (en)

Inventor

Ferdinando Ippolito

Siro Passi

Original Assignee

Ist Fisioterap Ospitalroma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-06-18

Filing date

1992-05-22

Publication date

1998-10-15

1992-05-22 Application filed by Ist Fisioterap Ospitalroma filed Critical Ist Fisioterap Ospitalroma

1998-10-15 Application granted granted Critical

1998-10-15 Publication of ATE171375T1 publication Critical patent/ATE171375T1/de

Links

201000004624 Dermatitis Diseases 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
206010039793 Seborrhoeic dermatitis Diseases 0.000 abstract 1
BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
229930003427 Vitamin E Natural products 0.000 abstract 1
238000009098 adjuvant therapy Methods 0.000 abstract 1
230000037213 diet Effects 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
230000002248 lipoperoxidative effect Effects 0.000 abstract 1
229930182817 methionine Natural products 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1
235000020777 polyunsaturated fatty acids Nutrition 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1
208000008742 seborrheic dermatitis Diseases 0.000 abstract 1
229910052711 selenium Inorganic materials 0.000 abstract 1
239000011669 selenium Substances 0.000 abstract 1
230000008491 skin homeostasis Effects 0.000 abstract 1
235000019165 vitamin E Nutrition 0.000 abstract 1
229940046009 vitamin E Drugs 0.000 abstract 1
239000011709 vitamin E Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Inorganic Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

AT92830252T 1991-06-18 1992-05-22 Pharmazeutische zusammensetzung, die als hilfsmittelbehandlung von seborrhoid-dermatitis, auch bei hiv-patienten, verwendbar ist ATE171375T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ITRM910435A IT1252717B (it)	1991-06-18	1991-06-18	Preparato farmaceutico da utilizzare quale trattamento coadiuvante della dermatite seborroica anche in soggetti hiv positivi

Publications (1)

Publication Number	Publication Date
ATE171375T1 true ATE171375T1 (de)	1998-10-15

Family

ID=11400207

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92830252T ATE171375T1 (de)	1991-06-18	1992-05-22	Pharmazeutische zusammensetzung, die als hilfsmittelbehandlung von seborrhoid-dermatitis, auch bei hiv-patienten, verwendbar ist

Country Status (6)

Country	Link
US (1)	US5290809A (de)
EP (1)	EP0519876B1 (de)
AT (1)	ATE171375T1 (de)
DE (1)	DE69227072T2 (de)
ES (1)	ES2122989T3 (de)
IT (1)	IT1252717B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5292773A (en) *	1990-02-14	1994-03-08	Hirsch Gerald P	Treating aids and HIV infection with methionine
GB2312621B (en) *	1996-05-02	1998-03-11	Pharma Nord Uk Limited	Anti-oxidant medicament
US5667791A (en) *	1996-05-31	1997-09-16	Thione International, Inc.	X-ray induced skin damage protective composition
IT1290907B1 (it) *	1997-01-31	1998-12-14	Idi Farmaceutici Spa	Composizione per prodotto dietetico efficace nel combattere lo stress ossidativo e il decadimento cellulare.
US6138683A (en) *	1997-09-19	2000-10-31	Thione International, Inc.	Smokeless tobacco products containing antioxidants
GB9722361D0 (en) *	1997-10-24	1997-12-17	Pharma Nord Uk Ltd	Pharmaceutical formulation for treating liver disorders
US5922346A (en) *	1997-12-01	1999-07-13	Thione International, Inc.	Antioxidant preparation
US6107349A (en) *	1998-04-16	2000-08-22	Mantynen; Philip R.	Method and composition for treating psoriasis
US6670392B2 (en) *	2001-04-06	2003-12-30	Bioadvantex Pharma Inc.	Compositions and methods for the prevention and treatment of human prostate cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2244468A1 (en) *	1973-07-31	1975-04-18	Passwater Richard	Anticarcinogenic food supplements - contg antioxidants and S-contg amino acids
SE8105887L (sv) *	1981-10-06	1983-04-07	Erland Johansson	Blandning for human tillforsel av selen som sparemne
DE3332507A1 (de) *	1983-09-09	1985-03-28	Henkel Kgaa	Sebosuppressive kosmetische mittel enthaltend benzylalkohol-derivate

1991
- 1991-06-18 IT ITRM910435A patent/IT1252717B/it active IP Right Grant
1992
- 1992-05-22 DE DE69227072T patent/DE69227072T2/de not_active Expired - Fee Related
- 1992-05-22 AT AT92830252T patent/ATE171375T1/de active
- 1992-05-22 EP EP92830252A patent/EP0519876B1/de not_active Expired - Lifetime
- 1992-05-22 ES ES92830252T patent/ES2122989T3/es not_active Expired - Lifetime
- 1992-06-02 US US07/892,190 patent/US5290809A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0519876B1 (de)	1998-09-23
DE69227072T2 (de)	1999-03-18
US5290809A (en)	1994-03-01
ES2122989T3 (es)	1999-01-01
ITRM910435A0 (it)	1991-06-18
DE69227072D1 (de)	1998-10-29
EP0519876A1 (de)	1992-12-23
ITRM910435A1 (it)	1992-12-18
IT1252717B (it)	1995-06-26

Similar Documents

Publication	Publication Date	Title
CA2033823C (en)	2002-04-09	Combination of gla or dgla and selenium in psychiatric disorder treatment
ATE75397T1 (de)	1992-05-15	Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
DE59108854D1 (de)	1997-10-23	Arzneimittel sowie deren herstellung und deren verwendung bei der bekämpfung von schmerzen und/oder entzündungen an tieren und menschen
BR0308799A (pt)	2007-01-09	co-glóbulos de dha e alecrim e método de uso
FR2634376B1 (fr)	1992-04-17	Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
DK1007020T3 (da)	2004-06-07	9-cis-retinoidsyre til cellemedierede immunsygdomme
DE3875425D1 (de)	1992-11-26	Vasokinetisch wirkende polyungesaettigte saeuren und sie enthaltende pharmazeutische oder kosmetische zubereitungen.
ES2040106T3 (es)	1993-10-01	Utilizacion de la acetil d-carnitina en el tratamiento terapeutico del glaucoma.
EP0232982A3 (de)	1990-02-14	Behandlung von Hautkrankheiten
IT8423086A1 (it)	1986-04-10	Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
DK0626176T3 (da)	2000-04-10	Næringsmiddel til personer, som undergår stråleterapi eller kemoterapi
ATE171375T1 (de)	1998-10-15	Pharmazeutische zusammensetzung, die als hilfsmittelbehandlung von seborrhoid-dermatitis, auch bei hiv-patienten, verwendbar ist
ATE183075T1 (de)	1999-08-15	Retinoid enthaltendes mittel
DE3683333D1 (de)	1992-02-20	Mittel zur behandlung von akne vulgaris und deren herstellung.
ATE69550T1 (de)	1991-12-15	Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
GB2210789A (en)	1989-06-21	Topical application for skin care
DE3750426D1 (de)	1994-09-29	Mittel zur Verbesserung spezifischer Eigenschaften des Blutes.
EP0357646A4 (en)	1991-05-08	Treatment of aged skin with oral 13-cis-retinoic acid
DE69018570D1 (de)	1995-05-18	Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
ATE5073T1 (de)	1983-11-15	5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE91079T1 (de)	1993-07-15	Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen.
DE3506881A1 (de)	1986-08-28	Vitamin e spray
DK192487D0 (da)	1987-04-14	Carbiovasculaere farmaceutiske praeparater, som er egnet til topisk indgivning
RU95109228A (ru)	1997-06-10	Способ лечения трофических язв
IT1232963B (it)	1992-03-11	Composizioni farmaceutiche topiche contenenti antiistaminici h2